Literature DB >> 16828411

Dermatology of androgen-related disorders.

Paulina A Essah1, Edmond P Wickham, Julia R Nunley, John E Nestler.   

Abstract

Hyperandrogenism in women can be caused by various conditions, the most prevalent of which is polycystic ovary syndrome. Common dermatologic manifestations of hyperandrogenism include hirsutism, acne, acanthosis nigricans, and androgenic alopecia. Hirsute women often have increased activity of 5 alpha-reductase, the enzyme that converts the androgen testosterone to its active metabolite, in hair follicles. Likewise, androgens affect the formation of acne by increasing sebum production from sebaceous glands in the skin. The diagnosis of polycystic ovary syndrome includes a complete history, physical examination with emphasis on evidence of androgen excess, and appropriate laboratory investigation to exclude other causes of hyperandrogenism. Treatments for the dermatologic conditions of hyperandrogenism include lifestyle modification, oral contraceptives, antiandrogens, and insulin-sensitizing medications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828411     DOI: 10.1016/j.clindermatol.2006.04.004

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  12 in total

1.  Race, rather than skin pigmentation, predicts facial hair growth in women.

Authors:  Emilia Javorsky; Alexis C Perkins; Greg Hillebrand; Kukizo Miyamoto; Alexa Boer Kimball
Journal:  J Clin Aesthet Dermatol       Date:  2014-05

Review 2.  The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Authors:  Ahmed Shah; Raed Alhusayen; Saeid Amini-Nik
Journal:  Inflamm Res       Date:  2017-06-27       Impact factor: 4.575

Review 3.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 4.  Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?

Authors:  Suvarna Satish Khadilkar
Journal:  J Obstet Gynaecol India       Date:  2016-03-11

5.  The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases.

Authors:  Faris Azzouni; Alejandro Godoy; Yun Li; James Mohler
Journal:  Adv Urol       Date:  2011-12-25

Review 6.  The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms.

Authors:  R Dumitrescu; C Mehedintu; I Briceag; V L Purcarea; D Hudita
Journal:  J Med Life       Date:  2015 Apr-Jun

7.  Complementary Therapies for Idiopathic Hirsutism: Topical Licorice as Promising Option.

Authors:  Gita Faghihi; Fariba Iraji; Bahareh Abtahi-Naeini; Bahar Saffar; Ali Saffaei; Mohsen Pourazizi; Abolfazl Aslani; Mohammad Ali Nilforoushzadeh
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-27       Impact factor: 2.629

8.  Androgenic alopecia is associated with less dietary soy, lower [corrected] blood vanadium and rs1160312 1 polymorphism in Taiwanese communities.

Authors:  Ching-Huang Lai; Nain-Feng Chu; Chi-Wen Chang; Shu-Li Wang; Hsin-Chou Yang; Chi-Ming Chu; Chu-Ting Chang; Ming-Huang Lin; Wu-Chien Chien; Sui-Lung Su; Yu-Ching Chou; Kang-Hua Chen; Wei-Ming Wang; Saou-Hsing Liou
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

Review 9.  Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.

Authors:  Joselyn Rojas; Mervin Chávez; Luis Olivar; Milagros Rojas; Jessenia Morillo; José Mejías; María Calvo; Valmore Bermúdez
Journal:  Int J Reprod Med       Date:  2014-01-28

10.  Evaluation of only the chin or lower abdomen for predicting hirsutism.

Authors:  Homeira Rashidi; Zohreh T Parizi; Mehdi Mohammadi
Journal:  Indian J Endocrinol Metab       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.